Login to Your Account

Psioxus to Elicit Immunological Response of Oncolytic Vaccine

By Nuala Moran
Staff Writer

Wednesday, June 26, 2013
LONDON – While oncolytic cancer vaccines are advancing in the clinic, there is as yet limited understanding of how they exert their effects on the immune system after infected tumor cells burst.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription